These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19874191)

  • 1. Binding conformations and QSAR of CA-4 analogs as tubulin inhibitors.
    Liao SY; Chen JC; Miao TF; Shen Y; Zheng KC
    J Enzyme Inhib Med Chem; 2010 Jun; 25(3):421-9. PubMed ID: 19874191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding orientations, QSAR, and molecular design of thiophene derivative inhibitors.
    Liao SY; Chen TJ; Miao TF; Qian L; Zheng KC
    Chem Biol Drug Des; 2009 Sep; 74(3):289-96. PubMed ID: 19703031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CoMFA and docking studies of 2-phenylindole derivatives with anticancer activity.
    Liao SY; Qian L; Miao TF; Lu HL; Zheng KC
    Eur J Med Chem; 2009 Jul; 44(7):2822-7. PubMed ID: 19167135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies.
    Hou T; Zhu L; Chen L; Xu X
    J Chem Inf Comput Sci; 2003; 43(1):273-87. PubMed ID: 12546563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular docking and 3D QSAR studies on 1-amino-2-phenyl-4-(piperidin-1-yl)-butanes based on the structural modeling of human CCR5 receptor.
    Xu Y; Liu H; Niu C; Luo C; Luo X; Shen J; Chen K; Jiang H
    Bioorg Med Chem; 2004 Dec; 12(23):6193-208. PubMed ID: 15519163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor-based 3D-QSAR studies of checkpoint Wee1 kinase inhibitors.
    Wichapong K; Lindner M; Pianwanit S; Kokpol S; Sippl W
    Eur J Med Chem; 2009 Apr; 44(4):1383-95. PubMed ID: 18976834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory mode of indole-2-carboxamide derivatives against HLGPa: molecular docking and 3D-QSAR analyses.
    Liu G; Zhang Z; Luo X; Shen J; Liu H; Shen X; Chen K; Jiang H
    Bioorg Med Chem; 2004 Aug; 12(15):4147-57. PubMed ID: 15246091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational prediction of the herbicidal activities of novel protoporphyrinogen oxidase inhibitors by quantitative structure-activity relationship model based on docking-guided active conformation.
    Lei B; Li J; Lu J; Du J; Liu H; Yao X
    J Agric Food Chem; 2009 Oct; 57(20):9593-8. PubMed ID: 19780536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploration of a binding mode of indole amide analogues as potent histone deacetylase inhibitors and 3D-QSAR analyses.
    Guo Y; Xiao J; Guo Z; Chu F; Cheng Y; Wu S
    Bioorg Med Chem; 2005 Sep; 13(18):5424-34. PubMed ID: 15963726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D-QSAR and molecular docking studies of selective agonists for the thyroid hormone receptor beta.
    Du J; Qin J; Liu H; Yao X
    J Mol Graph Model; 2008 Sep; 27(2):95-104. PubMed ID: 18436460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docking-based 3D-QSAR study for 11beta-HSD1 inhibitors.
    Lee JH; Kang NS; Yoo SE
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2479-90. PubMed ID: 18314331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined 3D-QSAR modeling and molecular docking study on quinoline derivatives as inhibitors of P-selectin.
    Zeng H; Cao R; Zhang H
    Chem Biol Drug Des; 2009 Dec; 74(6):596-610. PubMed ID: 19843078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined 3D-QSAR modeling and molecular docking study on indolinone derivatives as inhibitors of 3-phosphoinositide-dependent protein kinase-1.
    AbdulHameed MD; Hamza A; Liu J; Zhan CG
    J Chem Inf Model; 2008 Sep; 48(9):1760-72. PubMed ID: 18717540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular docking and 3D-QSAR CoMFA studies on indole inhibitors of GIIA secreted phospholipase A(2).
    Mouchlis VD; Mavromoustakos TM; Kokotos G
    J Chem Inf Model; 2010 Sep; 50(9):1589-601. PubMed ID: 20795712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D-QSAR studies of Checkpoint Kinase Weel inhibitors based on molecular docking, CoMFA and CoMSIA.
    Yi P; Fang X; Qiu M
    Eur J Med Chem; 2008 May; 43(5):925-38. PubMed ID: 17698256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3D-QSAR and docking studies of aldehyde inhibitors of human cathepsin K.
    Pan X; Tan N; Zeng G; Han H; Huang H
    Bioorg Med Chem; 2006 Apr; 14(8):2771-8. PubMed ID: 16377193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular modeling studies of pyridopurinone derivatives--potential phosphodiesterase 5 inhibitors.
    Srivani P; Srinivas E; Raghu R; Sastry GN
    J Mol Graph Model; 2007 Jul; 26(1):378-90. PubMed ID: 17307372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.
    Bhongade BA; Gadad AK
    J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D-QSAR and molecular docking studies of 1,3,5-triazene-2,4-diamine derivatives against r-RNA: novel bacterial translation inhibitors.
    Sekhar YN; Nayana MR; Sivakumari N; Ravikumar M; Mahmood SK
    J Mol Graph Model; 2008 Jun; 26(8):1338-52. PubMed ID: 18372201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular docking and 3D-QSAR studies of 2-substituted 1-indanone derivatives as acetylcholinesterase inhibitors.
    Shen LL; Liu GX; Tang Y
    Acta Pharmacol Sin; 2007 Dec; 28(12):2053-63. PubMed ID: 18031622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.